Pantherna Therapeutics
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $8.5M
Investors
- 2
About Pantherna Therapeutics
Founded in 2014 in Germany, Pantherna Therapeutics GmbH specializes in advanced lipid nanoparticle technology for organ-specific and cell-selective delivery of mRNA-based therapeutics. The CEO, Klaus Giese, leads the company as it strives to advance its innovative therapeutic approaches.Pantherna Therapeutics specializes in advanced lipid nanoparticle (LNP) technologies designed for the organ-specific and cell-selective delivery of mRNA-based therapeutics.LNP™, enable robust expression of therapeutic proteins targeted to specific tissues, particularly in clinical settings aimed at maximizing therapeutic impact. These innovations target conditions such as pulmonary edema, where restoring endothelial cell function in the lungs is crucial for stabilizing vascular barriers. Pantherna’s technologies are tailored for pharmacological precision, making them applicable in diverse therapeutic areas.The revenue model for Pantherna Therapeutics is primarily based on partnerships and collaborations with pharmaceutical and biotech companies, focusing on pre-clinical and clinical development stages. The company engages in B2B transactions, generating revenue through collaborative agreements that could involve licensing their proprietary technologies or co-developing mRNA therapies.LNP™, are not publicly available, but their partnership structures typically include milestones and deliverables aligning with the research and commercialization phases of therapeutic development. The company aims to enhance its product pipeline by advancing this critical program and is also targeting new markets for expansion, particularly in Europe and North America, by the end of 2023.
Who invested in Pantherna Therapeutics
2 investors across 2 rounds
See all investors in Pantherna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pantherna Therapeutics
Who invested in Pantherna Therapeutics?
Pantherna Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pantherna Therapeutics raised?
Pantherna Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pantherna Therapeutics last raise money?
Pantherna Therapeutics's most recent round on record is a Series B, in Jan 2022.
What does Pantherna Therapeutics do?
Founded in 2014 in Germany, Pantherna Therapeutics GmbH specializes in advanced lipid nanoparticle technology for organ-specific and cell-selective delivery of mRNA-based therapeutics.
Where is Pantherna Therapeutics headquartered?
Pantherna Therapeutics is headquartered in Germany.
Which VCs invest in companies like Pantherna Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Pantherna Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pantherna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.